via Health Care https://ift.tt/geVxOKw Lawyers for the FDA are expected to argue that pulling mifepristone would upend reproductive care for U.S. women and undermine the government’s scientific oversight of prescription drugs.
Conservative Texas judge weighs challenge to abortion pills
0 Comments